Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Aclaris Therapeutics Inc’s stock clocked out at $1.96, down -1.51% from its previous closing price of $1.99. In other words, the price has decreased by -$1.51 from its previous closing price. On the day, 0.55 million shares were traded.
Ratios:
To gain a deeper understanding of ACRS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.99 and its Current Ratio is at 3.99. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Leerink Partners Upgraded its Market Perform to Outperform on November 19, 2024, whereas the target price for the stock was revised from $2 to $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Mehra Anand bought 666,666 shares for $2.25 per share. The transaction valued at 1,499,998 led to the insider holds 710,030 shares of the business.
Leonard Braden Michael bought 206,025 shares of ACRS for $256,357 on Aug 05 ’24. The 10% Owner now owns 14,250,000 shares after completing the transaction at $1.24 per share. On Aug 02 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 167,544 shares for $1.29 each. As a result, the insider paid 216,400 and bolstered with 14,043,975 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 11.30 while its Price-to-Book (P/B) ratio in mrq is 1.36.
Stock Price History:
Over the past 52 weeks, ACRS has reached a high of $5.17, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -20.42%, while the 200-Day Moving Average is calculated to be 6.34%.
Shares Statistics:
A total of 107.85M shares are outstanding, with a floating share count of 91.41M. Insiders hold about 15.30% of the company’s shares, while institutions hold 68.59% stake in the company.
